Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder.
about
Structural basis for activation and non-canonical catalysis of the Rap GTPase activating protein domain of plexinDevelopment and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted TherapySS18 together with animal-specific factors defines human BAF-type SWI/SNF complexesSingle-cell sequencing analysis characterizes common and cell-lineage-specific mutations in a muscle-invasive bladder cancerNCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomesARID2: a new tumor suppressor gene in hepatocellular carcinomaA decade of exploring the cancer epigenome - biological and translational implicationsNetwork of Cancer Genes (NCG 3.0): integration and analysis of genetic and network properties of cancer genesIntegrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastomaEpigenetic modulators, modifiers and mediators in cancer aetiology and progressionTargeting EZH2 in cancerMammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomicsApplication Progress of CRISPR/Cas9 System for Gene Editing in Tumor ResearchChromodomain helicase DNA-binding proteins in stem cells and human developmental diseasesNormal and neoplastic urothelial stem cells: getting to the root of the problemEvasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.Minireview: Conversing with chromatin: the language of nuclear receptorsKATs in cancer: functions and therapiesEnhancer malfunction in cancerHistone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and preventionSWI/SNF chromatin remodeling complexes and cancerBladder cancer in 2011: the dawn of personalized medicineHijacked in cancer: the KMT2 (MLL) family of methyltransferasesControversies and challenges in research on urogenital schistosomiasis-associated bladder cancerSWI/SNF chromatin-remodeling factors: multiscale analyses and diverse functionsTargeting Hsp90 in urothelial carcinomaChromatin signatures of cancerProtein Profiling of Bladder Urothelial Cell CarcinomaMutational landscape of aggressive cutaneous squamous cell carcinomaGenetic and Epigenetic Alterations in Bladder CancerIntegrating Epigenomics into the Understanding of Biomedical InsightEZH2 in Bladder Cancer, a Promising Therapeutic TargetThe impact of the Cancer Genome Atlas on lung cancer.SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancerARID1A mutations in cancer: another epigenetic tumor suppressor?The SWI/SNF genetic blockade: effects in cell differentiation, cancer and developmental diseasesInactivating CUX1 mutations promote tumorigenesisComprehensive molecular characterization of urothelial bladder carcinomaGetting personalized cancer genome analysis into the clinic: the challenges in bioinformatics
P2860
Q21128780-A9AF059C-A251-4DCC-8E52-9B64C354452DQ21131727-61C969A2-746B-4DD2-85DC-07FA959FDC05Q21134718-8101D997-8F09-45F4-9BB2-51DD7E731A4FQ22001096-C25AA765-2036-4AA0-BD78-7212EB8741FCQ24596715-9572D108-5C3B-4906-A688-E86F3D49E445Q24607045-CD92FB53-E8B5-4086-97EE-F4BD3D7AA2CFQ24614467-3C407DF0-ED85-4F8B-8B68-098768D82279Q24619351-E66890B5-3A20-4B17-B2FB-46CC06E847FEQ24630017-0355AB8A-10CB-464D-BA4F-BC7681031929Q26766149-DB792AC3-7718-42DB-BDCE-EFF9EA33365DQ26769027-0194CFDD-03FA-4B2C-A27A-AAA756998FF5Q26776098-C41CB150-DBBB-4F69-A36A-3317752796D0Q26783442-278E8548-79D0-453B-AE1D-42725E3CD88AQ26822979-DF9D474E-7F23-4976-BFF0-1FAF94F9A7B9Q26825948-7A4E2DDA-6F4B-4F88-93B4-A65341B62F6BQ26827810-1D8E9A6C-E9EA-4F35-9DDD-C9975B01E42CQ26829103-3DFBCE55-9B5D-42A9-8C54-CC741C0B8B95Q26859355-AD8CED8E-6C64-4845-99A5-6F388877B7C4Q26861197-5519473C-A829-44E4-AC4D-72533B418CDBQ26994739-C7C83538-531C-4B1E-AAC4-8B9397EBF807Q26998657-B7375398-E9F3-4B39-9466-F4D506114043Q26998718-F8866DA9-81A8-4ECC-9A5E-A39E490FB660Q27006839-1C18DEF3-85BE-4360-8B96-F65D42C765CBQ27008499-D357146A-FC9C-41C0-A4D4-96418F2F8BF3Q27009284-DCF28515-01BF-4CED-B85F-63795A313123Q27023406-6CAE610F-B6B9-4CB7-B36C-AB9FDB08A6A7Q27024162-2D27D3E7-F9F8-4094-A8A1-C92119053398Q27324419-5F594787-5F55-42D2-ACFE-6A180FFAAB7EQ27853082-C4BC9BD6-6C7D-4B51-9DD3-C6D473FA130AQ28074732-6196E804-2A91-49AC-B308-699DF6BE7066Q28077579-7803F079-A422-4242-88F8-07400072CB0DQ28082054-A4CA5BC6-39D5-401A-B6A4-D487703B3440Q28084190-666AE7B4-3FD2-40A0-A9D1-0CF382FC2662Q28269618-DB349AC9-79B3-4094-95A6-E76C9F1C4C6CQ28273722-60089A1B-8564-49CB-9AC1-40B7F864619EQ28280605-CB56C0AC-5DB4-4B24-8E63-FA6ACBECB0FCQ28292392-29240271-0287-4D20-B968-57D24FC45AD6Q28303563-BC016FC0-F155-4CEF-AF43-F688EA2C7CC6Q28306864-0D5D2655-7870-416B-9198-57C3C74B5F30Q28394818-7EE67848-38BE-4768-9DFA-C851422363E1
P2860
Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 August 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Frequent mutations of chromati ...... cell carcinoma of the bladder.
@en
Frequent mutations of chromati ...... cell carcinoma of the bladder.
@nl
type
label
Frequent mutations of chromati ...... cell carcinoma of the bladder.
@en
Frequent mutations of chromati ...... cell carcinoma of the bladder.
@nl
prefLabel
Frequent mutations of chromati ...... cell carcinoma of the bladder.
@en
Frequent mutations of chromati ...... cell carcinoma of the bladder.
@nl
P2093
P2860
P50
P356
P1433
P1476
Frequent mutations of chromati ...... cell carcinoma of the bladder.
@en
P2093
Chunxiao Liu
Congjie Xu
Dafei Feng
Dan Theodorescu
Fangjian Zhou
Guangwu Guo
Hancheng Zheng
Hong Zhang
P2860
P2888
P304
P356
10.1038/NG.907
P407
P577
2011-08-07T00:00:00Z